Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Bupivacaine, Morphine), By Application (Spasticity, Pain), By Region (APAC, North America, Europe)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

The global Intrathecal Pumps market gathered revenue around USD 200 Million in 2020 and market is set to grow USD 430 Million by the end of 2027 and is estimated to expand at a modest CAGR of 6.1% during the prediction period 2021 to 2027.

Intrathecal Pumps Market  Size 2020 to 2027

Growth Factors:

The market There is an increasing product demand owing to the rising prevalence of cancer and other chronic pain conditions. In addition, the growing geriatric population and elimination or reduced use of other pain medications are factors contributing to the market growth. Chronic pain is the major cause of disability and is linked to a high economic and social burden.

Intrathecal pump is a highly efficient device that helps improve chronic pain conditions in patients with cancer and other related disorders. The increase in the prevalence of chronic pain conditions, the growing geriatric population, and the reduced or complete elimination of pain killers by patients are expected to contribute to the market growth. Intrathecal pumps are better than oral medications because they work directly in the Cerebrospinal Fluid (CSF), allowing drugs to be absorbed faster and more effectively.

Improved features, technological improvement, and a higher product demand will boost the market growth. Many global, as well as local key players in the market, are opting for different strategies. In February 2020, Flowonix Medical received the U.S. FDA approval to market its Prometra II Programmable Pump System. However, there are several drugs, which are not approved for intrathecal usage by the FDA. The FDA has also alerted patients and healthcare providers about the risk of using medications that have not been approved by the FDA.

As a result of the COVID-19 pandemic, the healthcare system had to deal with a lot of challenges. All outpatient and elective interventional procedures were limited or stopped to lower the impact of the virus outbreak. Also, most chronic pain therapies were regarded as non-urgent. The market, however, is projected to experience gradual growth with all services being restored. Furthermore, the increase in the geriatric population, which is prone to chronic pain, has increased the product demand. According to the National Institute on Aging (NIA), the geriatric population would be around 72 million by 2030.

Drug or medication delivery using an intrathecal pump helps improve comfort and relieve chronic pain, reduces the use of painkillers, allowing patients to resume their lives. Intrathecal drug delivery is used for treating the pain associated with conditions, such as unsuccessful spine and neck surgeries, chronic spine pain, neck pain, and abdominal pain. Moreover, it aids in the reduction of spasticity (muscle rigidity and spasms) and other such conditions. However, the U.S. Food and Drug Administration (FDA) has not yet approved all intrathecal pumps for usage. The FDA has issued a warning to healthcare providers and patients about the serious consequences of utilizing drugs that have not been approved by the FDA. Drugs that are licensed for intrathecal use must meet additional safety requirements. Dosing errors, infection, pump failure, opioid withdrawal, and other issues, such as muscle spasms, cognitive changes, pain, fever, vomiting, weakness, and heart or respiratory distress, are all possible risks, which may hinder the market growth.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Intrathecal Pumps market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Intrathecal Pumps market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 430 Million by 2027
Growth Rate CAGR of 6.1% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Type, application And Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Tricumed Medizintechnik GmbH; Codman and Shurtleff; Teleflex, Inc.; Flowonix Medical, Inc.; Zimmer Biomet; Medtronic.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Intrathecal Pumps market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Regional analysis:

North America dominated the market and accounted for the largest revenue share of over 41.0% in 2020. The high prevalence of cancer and other related conditions, such as chronic back and neck pain, which necessitates the use of pain medications, is expected to drive market growth. For instance, as per the CDC, chronic pain affects around 50 million in the U.S. Moreover, patient outcomes & safety are of the utmost importance and various projects have been established to improve healthcare quality at an affordable cost in the U.S. North America spends far more on healthcare than any other region, which is another factor contributing to its growth.

In Asia Pacific, the market is estimated to witness the fastest CAGR of 6.9% during the forecast period. The COVID-19 pandemic has highlighted the region’s health system’s inadequacies and flaws, as well as the interdependence of health security and economic stability. As a result, the region is making progress toward its objective of obtaining Universal Health Care (UHC). Furthermore, the growing geriatric population and changing lifestyles are expected to boost the market growth in the APAC region.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Intrathecal Pumps Market include:  Tricumed Medizintechnik GmbH; Codman and Shurtleff; Teleflex, Inc.; Flowonix Medical, Inc.; Zimmer Biomet; Medtronic

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

  • By Type
    • Baclofen
    • Bupivacaine
    • Clonidine
    • Morphine
    • Ziconotide
    • Others
  • By Application
    • Spasticity
    • Pain

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Intrathecal Pumps market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Intrathecal Pumps market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Intrathecal Pumps markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Key Points Covered in Intrathecal Pumps market Study:

  • Growth of Intrathecal Pumps in 2021
  • Market Estimates and Forecasts (2017-2027)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Intrathecal Pumps and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Intrathecal Pumps Consumption Analysis
  •  Intrathecal Pumps Production Analysis
  •  Intrathecal Pumps and Management

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Intrathecal Pumps Market, By Type

7.1.  Intrathecal Pumps Market, By Type, 2021-2027

7.1.1.     Baclofen

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Bupivacaine

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Clonidine

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Morphine

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Ziconotide

7.1.5.1.          Market Revenue and Forecast (2016-2027)

7.1.6.     Others

7.1.6.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Intrathecal Pumps Market, By Application

8.1.  Intrathecal Pumps Market, By Application, 2021-2027

8.1.1.     Spasticity

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Pain

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Intrathecal Pumps Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, By Type (2016-2027)

9.1.2.     Market Revenue and Forecast, By Application (2016-2027)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, By Type (2016-2027)

9.1.3.2.          Market Revenue and Forecast, By Application (2016-2027)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, By Type (2016-2027)

9.1.4.2.          Market Revenue and Forecast, By Application (2016-2027)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, By Type (2016-2027)

9.2.2.     Market Revenue and Forecast, By Application (2016-2027)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, By Type (2016-2027)

9.2.3.2.          Market Revenue and Forecast, By Application (2016-2027)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, By Type (2016-2027)

9.2.4.2.          Market Revenue and Forecast, By Application (2016-2027)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, By Type (2016-2027)

9.2.5.2.          Market Revenue and Forecast, By Application (2016-2027)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, By Type (2016-2027)

9.2.6.2.          Market Revenue and Forecast, By Application (2016-2027)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, By Type (2016-2027)

9.3.2.     Market Revenue and Forecast, By Application (2016-2027)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, By Type (2016-2027)

9.3.3.2.          Market Revenue and Forecast, By Application (2016-2027)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, By Type (2016-2027)

9.3.4.2.          Market Revenue and Forecast, By Application (2016-2027)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, By Type (2016-2027)

9.3.5.2.          Market Revenue and Forecast, By Application (2016-2027)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, By Type (2016-2027)

9.3.6.2.          Market Revenue and Forecast, By Application (2016-2027)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, By Type (2016-2027)

9.4.2.     Market Revenue and Forecast, By Application (2016-2027)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, By Type (2016-2027)

9.4.3.2.          Market Revenue and Forecast, By Application (2016-2027)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, By Type (2016-2027)

9.4.4.2.          Market Revenue and Forecast, By Application (2016-2027)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, By Type (2016-2027)

9.4.5.2.          Market Revenue and Forecast, By Application (2016-2027)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, By Type (2016-2027)

9.4.6.2.          Market Revenue and Forecast, By Application (2016-2027)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, By Type (2016-2027)

9.5.2.     Market Revenue and Forecast, By Application (2016-2027)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, By Type (2016-2027)

9.5.3.2.          Market Revenue and Forecast, By Application (2016-2027)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, By Type (2016-2027)

9.5.4.2.          Market Revenue and Forecast, By Application (2016-2027)

Chapter 10.   Company Profiles

10.1.                 Tricumed Medizintechnik GmbH

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 Codman and Shurtleff

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                 Teleflex, Inc

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 Flowonix Medical, Inc.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 Zimmer Biomet

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 Medtronic

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers